The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

Alok A. Khorana, Keith McCrae, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Michael B Streiff

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation'. Together they form a unique fingerprint.